Rhea J. Posedel - 23 Jan 2023 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Role
Director
Signature
/s/ Kenneth B Spink, Attorney-in-Fact
Issuer symbol
AEHR
Transactions as of
23 Jan 2023
Net transactions value
-$1,356,000
Form type
4
Filing time
25 Jan 2023, 15:00:50 UTC
Previous filing
24 Jan 2023
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEHR Common Stock Sale $658,000 -20,000 -3.5% $32.90 543,821 23 Jan 2023 by Trust F1
transaction AEHR Common Stock Sale $698,000 -20,000 -3.7% $34.90 523,821 23 Jan 2023 by Trust F1, F2
holding AEHR Common Stock 49,018 23 Jan 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2021.
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY 2022 of 143 shares on 11/18/2022. The closing price was $23.50 per share.

Remarks:

Ex. 24 - Power of Attorney